Potassium Magnesium Aspartate Glucose Injection

As a precursor of oxaloacetate in the body, aspartic acid plays an important role in the tricarboxylic acid cycle and participates in the ornithine cycle, combining ammonia and carbon dioxide to form urea. It has a strong affinity for cells and can be used as a carrier of potassium and magnesium ions to help them enter cells, increase the concentration of potassium and magnesium in cells, accelerate the tricarboxylic acid cycle of liver cells, and have a certain effect on improving liver function and reducing serum bilirubin concentration. It is metabolized and excreted from the body through the kidneys.

This product is a compound preparation, and its components are: each 1 ml contains 7.90~9.10 mg of L-aspartic acid (C4H7NO4), 1.06~1.22 mg of potassium (K), 0.39~0.45 mg of magnesium (Mg), and 47.5~52.5 mg of glucose (C6H12O6·H2O).

This product is a colorless clear liquid.

Electrolyte supplement. It can be used as an adjuvant treatment for hypokalemia, arrhythmias (mainly ventricular arrhythmias) caused by digitalis poisoning, and sequelae of myocarditis, congestive heart failure, and myocardial infarction.

Intravenous drip: 100ml~200ml each time, slowly intravenously drip, once a day, or as directed by your doctor.

(1) If the infusion rate is too fast, symptoms such as nausea, vomiting, vascular pain, facial flushing, and decreased blood pressure may occur. (2) In rare cases, the heart rate may slow down, which can be restored by slowing down the infusion rate or stopping the drug.

It is contraindicated in patients with hyperkalemia, acute and chronic renal failure, Addison's disease, Ⅲo atrioventricular block, and cardiogenic shock (blood pressure below 90 mmHg).

Hyperkalemia may occur when this product is used in combination with potassium-sparing diuretics and/or angiotensin-converting enzyme inhibitors (ACEI).

Keep in a dark place and sealed. The validity period is tentatively set at two years.

100ml: Aspartic acid 0.85g, potassium 0.114g, magnesium 0.042g, glucose 5g

Hangzhou Minsheng Pharmaceutical Co., Ltd.

• Founded in:

  1963-11-29

• Address:

  No. 36, Linping Avenue, Donghu Street, Linping District, Hangzhou City, Zhejiang Province

• Tax NO.:

  913301101430685558

• Registered Funds:

  88.97 million yuan

• Website:

  Log in to view

• Email:

  Log in to view